Zobrazeno 1 - 10
of 212
pro vyhledávání: '"FDA, the Food and Drug Administration"'
Publikováno v:
Indian Business Case Studies Volume I, 2022.
Externí odkaz:
https://doi.org/10.1093/oso/9780192869371.003.0011
Publikováno v:
Acta Pharmaceutica Sinica B. 12:1567-1590
HIV reverse transcriptase (RT) inhibitors are the important components of highly active antiretroviral therapies (HAARTs) for anti-HIV treatment and pre-exposure prophylaxis in clinical practice. Many RT inhibitors and their combination regimens have
Autor:
John B. Hagan, MD, Elizabeth Ender, MD, Rohit D. Divekar, MBBS, PhD, Thanai Pongdee, MD, Matthew A. Rank, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 1, Pp 69-76 (2022)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 1, Pp 69-76 (2022)
Objective: To estimate the potential risk for a future postmarket black box warning (BBW) of US Food and Drug Administration (FDA)-approved monoclonal antibodies (mAbs) because of the importance for medical clinicians to understand mAb risks and bene
Publikováno v:
JACC: Basic to Translational Science
Highlights • Knowledge of the genetic etiologies of cardiomyopathies has created novel opportunities for treatments. • Emerging treatments targets include gene therapy, myofilament function, protein quality control, and metabolism. • Considerat
Autor:
Gail A. Van Norman
Publikováno v:
JACC: Basic to Translational Science
Summary Phase I and II clinical trials increasingly combine therapeutic and toxicity endpoints. Recently, therapeutic agents have even achieved U.S. Food and Drug Agency approval based on early phase trials alone. These developments point to new chal
Autor:
Xianglin Zhang, Qi Zhang, Wenqing Tian, Chunqing Meng, Xiaodong Guo, Tingfang Sun, Keda Yu, Qiuyue Ding, Zekang Xiong, Bin Wu, Wancheng Zhang
Publikováno v:
Bioactive Materials, Vol 6, Iss 11, Pp 4163-4175 (2021)
Bioactive Materials
Bioactive Materials
In situ tissue engineering is a powerful strategy for the treatment of bone defects. It could overcome the limitations of traditional bone tissue engineering, which typically involves extensive cell expansion steps, low cell survival rates upon trans
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2469-2487 (2021)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Lipid-based formulations (LBFs) have demonstrated a great potential in enhancing the oral absorption of poorly water-soluble drugs. However, construction of in vitro and in vivo correlations (IVIVCs) for LBFs is quite challenging, owing to a complex
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2416-2448 (2021)
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2416-2448 (2021)
Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules than small molecular drugs due to their high selectivity and efficacy, but fewer side effects. Owing to the poor stability and limited permeability through gastro
Publikováno v:
Bioactive Materials
Bioactive Materials, Vol 6, Iss 7, Pp 1973-1987 (2021)
Bioactive Materials, Vol 6, Iss 7, Pp 1973-1987 (2021)
The tumor development and metastasis are closely related to the structure and function of the tumor microenvironment (TME). Recently, TME modulation strategies have attracted much attention in cancer immunotherapy. Despite the preliminary success of
Publikováno v:
Mayo Clinic Proceedings
The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less prone to severe illness; however, sex-disaggregated data are incomplete, leaving room for misin